Case report: A Fusarium fungaemia;Olgu raporu: Bir Fusarium fungemisi

Mikrobiyoloji Bulteni

Volumn 38, Issue 3, 2004, Pages 265-271

  Yücesoy, Mine ^a   Ergon, M Cem ^a   Ören, Hale ^a   Gülay, Zeynep ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Acute lymphoblastic leukemia; Fungaemia; Fusarium thapsinum

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE;

ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; CASE REPORT; CENTRAL VENOUS CATHETERIZATION; CHEMICALLY INDUCED DISORDER; CHILD; FEMALE; FEVER; FUNGEMIA; FUSARIUM; HUMAN; INDWELLING CATHETER; ISOLATION AND PURIFICATION; LEUKOPENIA; MICROBIOLOGY; NEUTROPENIA;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ANTINEOPLASTIC AGENTS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CHILD; FEMALE; FEVER; FUNGEMIA; FUSARIUM; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ITRACONAZOLE; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKOPENIA; NEUTROPENIA;

EID: 28744443644     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Sigler L, Verwij PE: Aspergillus, Fusarium and other opportunistic moniliaceous fungi, p: 1726-1760. In: Murray PR, Baron EJ, Pfaller MA, Jorgensen JH, Yolken RH (eds), Manual of Clinical Microbiology. 2003, 8th ed. Amer Soc Microb, Washington DC.
2. Hospenthal DR, Bennett JE: Miscellaneous fungi and Prototheca, p: 2772-2780. In: Mandell GL, Bennett JE, Dolin R (eds), Principles and Practice of Infectious Diseases. 2000, 5th ed. Churchill Livingstone, Pennsylvania.
3. De Pauw BE, Donnelly JP: Infections in the immunocompromised host: General principles, p: 3079-3090. In: Mandell GL, Bennett JE, Dolin R (eds), Principles and Practice of Infectious Diseases. 2000, 5th ed. Churchill Livingstone, Pennsylvania.
4. Vartivarian SE, Anaissie EJ, Bodey GP: Emerging fungal pathogens in immunocompromised patients: Classification, diagnosis and management. Clin Infect Dis 1993, 17 (Suppl 2): S487-S491.
5. Perfect JR, Schell WA: The new fungal opportunists are coming. Clin Infect Dis 1996, 22 (Suppl 2): S112-S118.
6. Fleming RV, Walsh TJ, Anaissie EJ: Emerging and less common fungal pathogens. Infect Dis Clin N Am 2002, 16: 915-933.
7. Larone DH: Hyaline Hyphomycetes, p: 255-289. In: Medically Important Fungi: A Guide to Identification. 2002, 4th ed. Amer Soc Microb, Washington DC.
8. de Hoog GS, Guarro J, Gené J, Figueras MJ: Atlas of Clinical Fungi, p: 681-705. 2000, 2nd ed. Centraalbureau woor Schimmelcultures, Utrecht, Netherlands.
9. National Comittee for Clinical Laboratory Standards: Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi. Proposed standard M38-P.1997, NCCLS, Wayne, Philadelphia.
10. Ener B: Nadir görülen fιrsatçι mikozlar, s: 1105-1109. Mutlu G, imir T, Cengiz T, Ustaçelebi Ş, Tümbay E, Mete Ö (ed), Temel ve Klinik Mikrobiyoloji. 1999, Güneş Kitabevi, Ankara.
11. Yildiran ŞT, Kömürcü S, Saraçli MA, et al: Fusarium fungaemia in severely neutropenic patients. Mycoses 1998, 41: 467-469.
12. Segal BH, Walsh TJ, Liu JM, Wilson JD, Kwong-Chung KJ: Invasive infection with Fusarium chlamydosporum in a patient with aplastic anemia. J Clin Microbiol 1998, 36: 1772-1776.
13. Nirenberg HI, O'Donnel K: New Fusarium species and combinations within the Gibberella fujikuroi species complex. Mycologia 1998, 90: 434-458.
14. Guarro J, Gené J: Opportunistic fusarial infections in humans, Eur J Clin Microbiol Infect Dis 1995, 14: 741-754.
15. Perfect JR: New therapies for rare and refractory fungal infections. 13th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 10-13, 2003. Glasgow, England.
16. Ankan S, Lozano-Chiu M, Paetznick V, Nangia S, Rex JH: Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species. J Clin Microbiol 1999, 37: 3946-3951.
17. Pfaller MA, Messer SA, Hollis RJ, Jones RN, and Sentry Participants Group: Antifungal activities of posoconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: Report from SENTRY antimicrobial surveillance program, 2000. Antimicrob Agents Chemother 2002, 46: 1032-1037.
18. Espinel-Ingroff A: Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi. J Clin Microbiol 2001, 39: 1360-1367.